Full article view 2017-03-17T10:17:44+00:00
Back to News & Insights »

Pat Devitt Risse in Life Science Leader: Bet On Biomarkers for Better Outcomes

 

In the latest edition of Life Science Leader, Precision Oncology president Pat Devitt Risse contributes a new guest column: “Bet On Biomarkers for Better Outcomes.” In the article, Pat advocates for greater use of biomarkers used to accurately pinpoint the patient population that will benefit from a drug during clinical trials.